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Epilepsy is one of the most prevalent neurological diseases worldwide. The mortality rates are consider-
ably higher in people with epilepsy than would be expected in a healthy population and sudden unex-
pected death in epilepsy (SUDEP) is the most frequent epilepsy-related category of death. Most
children had seizures before the occurrence of the fatal event and autonomic dysfunction has been pro-
posed as mechanisms of sudden death in this population. Is this sense, we raise the question whether is
there a possible relationship between SUDEP in children and fungal pathogenicity. Indeed, the role of fun-
gal pathogenicity in the establishment of epilepsy and even in cases of SUDEP has an interesting role in
this scenario. Moreover, maternal infections during pregnancy have been associated with an increased
risk for several brain disorders, however, this fact is still considered uncertain with respect to epilepsy.
Based on this information and considering that maternal-fetal yeast infection is directly associated
with an increased risk for epilepsy in childhood and that some patients have medically intractable epi-
lepsy, the chances of these children suffering a fatal event cannot be overlooked by healthcare profession-
als. Thus, as exact knowledge regarding this association is lacking, some possibilities could be evaluated,
and more emphasis on translational research would contribute to further progress to the knowledge of
SUDEP.
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worldwide. A major proportion of patients with epilepsy falls in
the pediatric group (18 years old or less), and approximately 25%
of those patients have medically intractable epilepsy [1]. Unfortu-
nately, mortality rates are considerably higher in people with epi-
lepsy than would be expected in a healthy population and sudden
unexpected death in epilepsy (SUDEP) is the most frequent epi-
lepsy-related category of death [2]. Currently, SUDEP has an inci-
dence among adults between 1:500 and 1:1000 patient-years [3].
SUDEP is mainly, but not exclusively, an issue in patients with
refractory epilepsy [3]. In parallel, although different mechanisms
may play separate roles in different cases, mechanisms to play a
role in SUDEP are autonomic, i.e., respiratory (central apnea) and
cardiovascular (cardiac arrhythmias) [3]. On the other hand, it is
important to emphasize that SUDEP has been less studied in child-
hood, probably because the incidence of sudden death is higher in
adults than in children [4]. Actually, SUDEP occurs more commonly62, Edifício Leal Prado, CEP
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evier OA license.in children with refractoriness of the epileptic condition and the
literature reports rates of SUDEP in childhood between 1.1 and
4.3/10,000 patient years [4,5]. Furthermore, most children had sei-
zures before the occurrence of the fatal event and autonomic dys-
function has been proposed as mechanisms of sudden death in this
population [4,5]. Following this line of reasoning, we reviewed the
incidence of SUDEP in a cohort of children in our epilepsy unit over
an 8-year period [6]. Brieﬂy, from 835 patients evaluated, 12 had
suffered SUDEP and nearly all of the SUDEP cases in our children
are related to chronic uncontrolled epilepsy (daily-50.0%, two to
four/week-41.7%, monthly-8.3%) [6]. Thus, our study is totally in
agreement with previous results evaluated in children and adults
with epilepsy, where increased mortality was recorded in those
individuals who had not responded to treatment [2–5]. Taken all
these data together, is there a possible relationship between SUDEP
in children and fungal pathogenicity? Yes, there is.
Firstly, we have to remember that the most common risk factors
for epilepsy are cerebrovascular disease, brain tumors, alcohol,
traumatic head injuries, malformations of cortical development,
genetic inheritance, and infections of the central nervous system
[2]. In resource-poor countries, endemic infections seem to be ma-
Fig. 1. Representation of the possible link between yeast infection and SUDEP.
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who have epilepsy live in countries with poor resources and the
major cause of this higher rate is related with endemic parasitic
diseases [2]. In these lines, the role of fungal pathogenicity in the
establishment of epilepsy and even in cases of SUDEP has an inter-
esting role in this scenario. As we know, multiple factors inﬂuence
the outcome of fungal infection of the central nervous system
(CNS) [7]. Although 70,000–1500,000 fungal species exist and
nearly 300 species have been associated with human infection,
there are about a dozen yeasts and about 30 molds that are com-
monly identiﬁed as human pathogens encountered in the CNS
[7,8].
Second, maternal infections during pregnancy have been associ-
ated with an increased risk for several brain disorders, however,
this fact is still considered uncertain with respect to epilepsy [8].
What is known is that the seasonal pattern of births of children
with epilepsy indicates that infections or other environmental
exposures with seasonal variation may play a causal role in the
cause of epilepsy [8,9]. In 2006, Whitehead et al. [10] examined
the effect of pregnancy and neonatal factors on the subsequent
development of childhood epilepsy in a population-based cohort
study. There were 648 new cases of epilepsy diagnosed among
124,207 live births, for an overall rate of 63 per 100,000 person-
years. In adjusted analyzes, maternal infections during pregnancy
were associated with an increased incidence for epilepsy in child-
hood [10]. Two years later, Sun et al. estimated directly the associ-
ation between prenatal exposure to maternal infections and the
subsequent risk for epilepsy in childhood [8]. Brieﬂy, the authors
clearly demonstrated that prenatal exposure to some maternal
infections, including vaginal yeast infection, was associated with
an increased risk for epilepsy in childhood [8].
Based on this information and considering that maternal-fetal
yeast infection is directly associated with an increased risk for epi-
lepsy in childhood and that 1/4 of those patients have medically
intractable epilepsy, the chances of these children suffering a fatal
event cannot be overlooked by healthcare professionals. Thus, as
exact knowledge regarding this association is lacking, some possi-
bilities could be evaluated (see Fig. 1).
In this context, an interesting proposal would follow the current
principles of translational research. As well established, the excit-
ing discoveries in biomedical research and their promise for the fu-
ture of medicine continue to expand. One of the reasons of such
advancement is due to the onset of translational research. In gen-
eral lines, the term translational research speciﬁcally aims at tak-
ing the integration of the advancements in basic science with
clinical trials, taking research from the ‘‘bench-to-bedside’’ [11].
This perspective will improve health and, in doing so, gain knowl-
edge for people with some chronic diseases [11], but can still be
considered rare among epileptologists and infectologists. Obvi-
ously, although this possibility still only present a speculative ba-
sis, this perspective is quite plausible. For that, we suggest that
after the diagnosis of vaginal yeast infection in the pregnant wo-
man have been performed, should be part of clinical routine of
the infectologist contact the epileptologist to let you on notice.
As a considerable percentage of mothers with vaginal yeast infec-
tion can lead to children with epilepsy and 25% of these children
may be refractory to pharmacological treatment and unfortu-
nately, may also have chances of dying suddenly, both infectolo-
gists and epileptologists should work in convergence and always
treated the patients in a ‘‘translational manner’’.
In sum, more emphasis will be put on translational research.
Obviously, future work in this area will examine that potential,
and the degree to which it is being achieved, however, we mustremember that we are in an era that further progress will depend
upon continued collaborative efforts by the translational scientiﬁc
community.
Conﬂict of interest
None declared.
References
[1] Carter OS. Surgical treatment of medically refractory epilepsy in childhood.
Brain Dev 2001;23:199–207.
[2] Duncan JS, Sander JW, Sisodiya SM, Walker MC. Adult epilepsy. Lancet
2006;367:1087–100.
[3] Surges R, Thijs RD, Tan HL, Sander JW. Sudden unexpected death in epilepsy:
risk factors and potential pathomechanisms. Nat Rev Neurol 2009;5:492–504.
[4] Milroy C. Sudden unexpected death in epilepsy in childhood. Forensic Sci Med
Pathol 2011;7:336–40.
[5] Meyer S, Shamdeen MG, Gottschling S, Strittmatter M, Gortner L. Sudden
unexpected death in epilepsy in children. J Paediatr Child Health
2011;47:326–31.
[6] Terra VT, Scorza FA, Sakamoto AC, Pinto KGFD, Fernandes RMF, Arida RM, et al.
Does sudden unexpected death in children with epilepsy occur more
frequently in those with high seizure frequency? Arq Neuropsiquiatr
2009;67:1001–2.
[7] Redmond A, Dancer C, Woods ML. Fungal infections of the central nervous
system: a review of fungal pathogens and treatment. Neurol India
2007;55:251–9.
[8] Sun Y, Vestergaard M, Christensen J, Nahmias AJ, Olsen J. Prenatal exposure to
maternal infections and epilepsy in childhood: a population-based cohort
study. Pediatrics 2008;121:e1100–7.
[9] Procopio M, Marriott PK. Seasonality of birth in epilepsy: a danish study. Acta
Neurol Scand 1998;98:297–301.
[10] Whitehead E, Dodds L, Joseph KS, Gordon KE, Wood E, Allen AC, et al. Relation
of pregnancy and neonatal factors to subsequent development of childhood
epilepsy: a population-based cohort study. Pediatrics 2006;117:1298–306.
[11] Goldblatt EM, Lee WH. From bench to bedside: the growing use of
translational research in cancer medicine. Am J Transl Res 2010;2:1–18.
